Phase II Study With Cabozantinib in Patients With RET Positive NSCLC
Clinical trial NCT04131543 · UNKNOWN
Trial details
- NCT number
- NCT04131543
- Sponsor
- University of Bologna
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-07
- Primary completion
- 2020-08-07
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.